A nuclear function for the presenilin 1 neuronal partner NPRAP/δ-catenin

Journal of Alzheimer's Disease

Volumn 27, Issue 2, 2011, Pages 307-316

  Koutras, Carolina ^a,b   Lessard, Christian B ^a,c   Lévesque, Georges ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; butyrylcholinesterase; NPRAP delta catenin; presenilin

Indexed keywords

ARMADILLO DOMAIN PROTEIN; CATENIN; DELTA CATENIN; PLAKOPHILIN; PRESENILIN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL JUNCTION; CELL NUCLEUS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 81855211125     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110536     Document Type: Article

References (68)

1. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7, 137-152.
2. Davies P, Maloney AJ (1976) Selective loss of central cholin-ergic neurons in Alzheimer's disease. Lancet 2, 1403. (Pubitemid 8004505)
3. Pike CJ, Cummings BJ, Cotman CW (1995) Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 132, 172-179.
4. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1, 189. (Pubitemid 8020501)
5. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706. (Pubitemid 21912142)
6. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, et al (1995) Familial Alzheimer's disease inkindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
7. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloningofagene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
8. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, et al (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235, 885-890. (Pubitemid 17019126)
9. Lal M, Caplan M (2011) Regulated intramembrane proteoly-sis: Signaling pathways and biological functions. Physiology 26, 34-44.
10. Steiner H (2008) The catalytic core of gamma-secretase: Pre-senilin revisited. Curr Alzheimer Res 5, 147-157. (Pubitemid 351536339)
11. Price JL, Morris JC (1999) Tangles and plaques in nonde-mented aging and "preclinical" Alzheimer's disease. Ann Neurol 45, 358-368. (Pubitemid 29120041)
12. Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC (2009) Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer's disease. Neurobiol Aging 30, 1026-1036.
13. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13, 179-189.
14. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837-1844. (Pubitemid 44049813)
15. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58, 376-388. (Pubitemid 29187900)
16. Heilig EA, Xia WM, Shen J, Kelleher RJ (2010) A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. J Biol Chem 285, 22350-22359.
17. Amtul Z, Lewis PA, Piper S, Crook R, Baker M, Findlay K, Singleton A, Hogg M, Younkin L, Younkin SG, Hardy J, Hutton M, Boeve BF, Tang-Wai D, Golde TE (2002) A presenilin 1 mutation associated with familial frontotempo-ral dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiol Dis 9, 269-273. (Pubitemid 34261221)
18. Raux G, Gantier R, Thomas-Anterion C, Boulliat J, Verpillat P, Hannequin D, Brice A, Frebourg T, Campion D (2000) Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation. Neurology 55, 1577-1578.
19. Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rade-makers R, Saerens J, Pickut BA, Peeters K, van den Broeck M, Vennekens K, Claes S, Cruts M, Cras P, Martin JJ, Van Broeckhoven C, De Deyn PP (2004) A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 55, 617-626. (Pubitemid 38544321)
20. Hass MR, Sato C, Kopan R, Zhao G (2009) Presenilin: RIP and beyond. Semin Cell Dev Biol 20, 201-210.
21. Levesque G, Yu G, Nishimura M, Zhang DM, Levesque L, Yu H, Xu D, Liang Y, Rogaeva E, Ikeda M, Duthie M, Murgolo N, Wang L, Vander Vere P, Bayne ML, Strader CD, Rommens JM, Fraser PE, St George-Hyslop P (1999) Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin. J Neurochem 72, 999-1008. (Pubitemid 29085014)
22. Raurell I, Castano J, Franci C, Garcia de Herreros A, Dunach M (2006) Presenilin-1 interacts with plakoglobin and enhances plakoglobin-Tcf-4 association Implications for the regulation of beta-catenin/Tcf-4-dependent transcription. J Biol Chem 281, 1401-1411.
23. Baki L, Marambaud P, Efthimiopoulos S, Georgakopoulos A, Wen P, Cui W, Shioi J, Koo E, Ozawa M, Friedrich VL Jr, Robakis NK (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc Natl Acad Sci USA 98, 2381-2386. (Pubitemid 32209491)
24. Daniel JM (2007) Dancinginand outofthenucleus: p120 (ctn) and the transcription factor Kaiso. Biochim Biophys Acta 1773, 59-68. (Pubitemid 44932107)
25. Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y (2004) Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcrip-tional activity in beta-catenin-deficient cell line. Oncogene 23, 964-972. (Pubitemid 38250942)
26. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480.
27. Tanahashi H, Tabira T (1999) Isolationofhuman delta-catenin and its binding specificity with presenilin 1. Neuroreport 10, 563-568. (Pubitemid 29333283)
28. Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, Lovett M, Kosik KS (1997) Presenilin 1interaction in the brain with a novel member of the Armadillo family. Neuroreport 8, 2085-2090. (Pubitemid 27314338)
29. Carnahan RH, Rokas A, Gaucher EA, Reynolds AB (2010) The molecular evolution of the p120-catenin subfamily and its functional associations. PLoS One 5, e15747.
30. Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF, Gardiner RA (2002) Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. Int J Cancer 100, 228-237. (Pubitemid 34666199)
31. Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, Chen Y-h (2005) Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer. Hum Pathol 36, 1037-1048. (Pubitemid 41443254)
32. Rodova M, Kelly KF, VanSaun M, Daniel JM, Werle MJ (2004) Regulation of the rapsyn promoter by kaiso and delta-catenin. Mol Cell Biol 24, 7188-7196. (Pubitemid 39014444)
33. Medina M, Marinescu RC, Overhauser J, Kosik KS (2000) Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics 63, 157-164. (Pubitemid 30131941)
34. Overhauser J, Huang X, Gersh M, Wilson W, McMahon J, Bengtsson U, Rojas K, Meyer M, Wasmuth JJ (1994) Molecular and phenotypic mapping of the short arm of chromosome 5: Sublocalization of the critical region for the cri-du-chat syndrome. Hum Mol Genet 3, 247-252. (Pubitemid 24060938)
35. Israely I, Costa RM, Xie CW, Silva AJ, Kosik KS, Liu X (2004) Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction. Curr Biol 14, 1657-1663. (Pubitemid 39239363)
36. Xin H, Pereira-Smith OM, Choubey D (2004) Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23, 6209-6217. (Pubitemid 39215291)
37. Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, Shelby S, Zhou L, Silverman RH, Hassel BA (2007) Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene 26, 3081-3088. (Pubitemid 46733645)
38. Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyryl-cholinesterase to hydrolyze acetylcholine. Neuroscience 110, 627-639. (Pubitemid 34270534)
39. Guillozet AL, Smiley JF, Mash DC, Mesulam MM (1997) Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol 42, 909-918. (Pubitemid 28008422)
40. Lehmann DJ, Nagy Z, Litchfield S, Borja MC, Smith AD (2000) Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaquesinthe temporal cortex in late-onset Alzheimer's disease. Hum Genet 106, 447-452. (Pubitemid 30237513)
41. Giacobini E, Spiegel R, Enz A, Veroff AE, Cutler NR (2002) Inhibition of acetyl-and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: Correlation with cognitive benefit. J Neural Transm 109, 1053-1065. (Pubitemid 34762344)
42. Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem Pharmacol 7, 88-95.
43. Johnstone RW, Kerry JA, Trapani JA (1998) The human interferon-inducible protein, IFI 16, is a repressor of transcription. J Biol Chem 273, 17172-17177. (Pubitemid 28311754)
44. Liang SL, Quirk D, Zhou AM (2006) RNase L: Its biological roles and regulation. Iubmb Life 58, 508-514. (Pubitemid 44470236)
45. Jay P, Goze C, Marsollier C, Taviaux S, Hardelin JP, Koop-man P, Berta P (1995) The human SOX11 gene: Cloning, chromosomal assignment and tissue expression. Genomics 29, 541-545.
46. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39, 17-23. (Pubitemid 46026496)
47. Casagolda D, Del Valle-Perez B, Valls G, Lugilde E, Viny-oles M, Casado-Vela J, Solanas G, Batlle E, Reynolds AB, Casal JI, de Herreros AG, Dunach M (2010) A p120-catenin-CK1epsilon complex regulates Wnt signaling. J Cell Sci 123, 2621-2631.
48. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, Brunak S (2004) Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 17, 527-536. (Pubitemid 39487532)
49. Oh M, Kim H, Yang I, Park JH, Cong WT, Baek MC, Bareiss S, Ki H, Lu Q, No J, Kwon I, Choi JK, Kim K (2009) GSK-3 phosphorylates delta-catenin and negatively regulates its stability via ubiquitination/proteosome-mediated proteolysis. J Biol Chem 284, 28579-28589.
50. Gazit A, Yaniv A, Bafico A, Pramila T, Igarashi M, Kitajewski J, Aaronson SA (1999) Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response. Oncogene 18, 5959-5966. (Pubitemid 29535007)
51. Darvesh S, Hopkins DA, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 4, 131-138. (Pubitemid 37271383)
52. McIlroy SP, Crawford VL, Dynan KB, McGleenon BM, Vahidassr MD, Lawson JT, Passmore AP (2000) Butyryl-cholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet 37, 182-185. (Pubitemid 30245911)
53. Wiebusch H, Poirier J, Sevigny P, Schappert K (1999) Further evidence forasynergisticassociation between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet 104, 158-163. (Pubitemid 29123608)
54. Ki CS, Na DL, Kim JW, Kim HJ, Kim DK, Yoon BK (1999) No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am J Med Genet 88, 113-115. (Pubitemid 29156444)
55. Alvarez-Arcaya A, Combarros O, Llorca J, Sanchez-Guerra M, Berciano J, Fernandez-Viadero C, Pena N (2000) The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women. Acta Neurol Scand 102, 350-353.
56. Darvesh S, Kumar R, Roberts S, Walsh R, Martin E (2001) Butyrylcholinesterase-mediated enhancement of the enzymatic activity of trypsin. Cell Mol Neurobiol 21, 285-296. (Pubitemid 32852780)
57. Wright CI, Geula CG, Mesulam MM (1993) Protease inhibitors andindoleaminesselectively inhibit cholinesterases in the histopathologic structures of Alzheimer-disease. Proc Natl Acad Sci USA 90, 683-686. (Pubitemid 23028928)
58. Diamant S, Podoly E, Friedler A, Ligumsky H, Livnah O, Soreq H (2006) Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci USA 103, 8628-8633. (Pubitemid 43878071)
59. Zhang J-Y, Wang Y, Zhang D, Yang Z-Q, Dong X-J, Jiang G-Y, Zhang P-X, Dai S-D, Dong Q-Z, Han Y, Zhang S, Cui Q-Z, Wang E-H (2010) delta-Catenin promotes malignant pheno-type of non-small cell lung cancer by non-competitive binding to E-cadherin with p120 ctnin cytoplasm. J Pathol 222, 76-88.
60. Wang T, Chen YH, Hong H, Zeng Y, Zhang J, Lu JP, Jeansonne B, Lu Q (2009) Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer. Oncogene 28, 555-564.
61. Zheng M, Simon R, Mirlacher M, Maurer R, Gasser T, Forster T, Diener PA, Mihatsch MJ, Sauter G, Schraml P (2004) TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol 165, 63-69. (Pubitemid 38821814)
62. Huang FY, Chiu PM, Tam KF, Kwok YKY, Lau ET, Tang MHY, Ng TY, Liu VWS, Cheung ANY, Ngan HYS (2006) Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer. Gynecol Oncol 103, 219-225. (Pubitemid 44374692)
63. Westbrook TF, Martin ES, Schlabach MR, Leng Y, Liang AC, Feng B, Zhao JJ, Roberts TM, Mandel G, Hannon GJ, Depinho RA, Chin L, Elledge SJ (2005) A genetic screen for candidate tumor suppressors identifies REST. Cell 121, 837-848. (Pubitemid 40806416)
64. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA (2010) Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 107, 18545-18550.
65. Kallakury BV, Sheehan CE, Winn-Deen E, Oliver J, Fisher HA, Kaufman RP, Jr, Ross JS (2001) Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 92, 2786-2795. (Pubitemid 33091915)
66. Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130, 223-233. (Pubitemid 47081143)
67. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS (2005) BRAFE600-associated senescencelike cell cycle arrest of human naevi. Nature 436, 720-724. (Pubitemid 41117276)
68. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP (2005) Crucial role of p53-dependent cellularsenescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730. (Pubitemid 41117277)